Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.
Capper, David
Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. [electronic resource] - The American journal of surgical pathology Aug 2010 - 1199-204 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1532-0979
10.1097/PAS.0b013e3181e7740d doi
Antibody Specificity
Biomarkers, Tumor--analysis
Biopsy
Brain Neoplasms--enzymology
Diagnosis, Differential
Glioma--enzymology
Gliosis--diagnosis
Humans
Immunohistochemistry
Isocitrate Dehydrogenase--analysis
Mutation
Neoplasm Staging
Neuroglia--enzymology
Predictive Value of Tests
Sensitivity and Specificity
Treatment Outcome
Tumor Suppressor Protein p53--analysis
WT1 Proteins--analysis
Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. [electronic resource] - The American journal of surgical pathology Aug 2010 - 1199-204 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1532-0979
10.1097/PAS.0b013e3181e7740d doi
Antibody Specificity
Biomarkers, Tumor--analysis
Biopsy
Brain Neoplasms--enzymology
Diagnosis, Differential
Glioma--enzymology
Gliosis--diagnosis
Humans
Immunohistochemistry
Isocitrate Dehydrogenase--analysis
Mutation
Neoplasm Staging
Neuroglia--enzymology
Predictive Value of Tests
Sensitivity and Specificity
Treatment Outcome
Tumor Suppressor Protein p53--analysis
WT1 Proteins--analysis